Proton pump inhibitors and cardiovascular adverse effects: Real or surreal worries?
Sign Up to like & getrecommendations! Published in 2019 at "European journal of internal medicine"
DOI: 10.1016/j.ejim.2019.11.017
Abstract: Proton pump inhibitors (PPIs) are among the most widely prescribed agents, either for treatment or prophylaxis of gastrointestinal (GI) disease, that are often administered for prolonged or chronic use. Patients with cardiovascular (CV) disease frequently… read more here.
Keywords: pump inhibitors; use; inhibitors cardiovascular; proton pump ... See more keywords
Factor XI inhibitors: cardiovascular perspectives.
Sign Up to like & getrecommendations! Published in 2022 at "European heart journal"
DOI: 10.1093/eurheartj/ehac464
Abstract: Anticoagulants are the cornerstone for prevention and treatment of thrombosis but are not completely effective, and concerns about the risk of bleeding continue to limit their uptake. Animal studies and experience from patients with genetic… read more here.
Keywords: factor inhibitors; factor; inhibitors cardiovascular; cardiovascular perspectives ... See more keywords
Sodium‐glucose co‐transporter‐2 inhibitors and cardiovascular outcome studies in people with type 2 diabetes: From efficacy to effectiveness
Sign Up to like & getrecommendations! Published in 2018 at "Diabetes"
DOI: 10.1111/dom.13142
Abstract: Cardiovascular disease remains the main cause of morbidity and mortality in people with diabetes, and is also the largest contributor to healthcare costs in this population(1). read more here.
Keywords: sodium glucose; glucose transporter; inhibitors cardiovascular; outcome studies ... See more keywords